NEW YORK, May 4 (Reuters) - Shares of Acadia Pharmaceuticals Inc (ACAD.O) more than doubled to $2.33 in premarket trade on Monday, after the company said it entered into a deal with a unit of Biovail Corp (BVF.N) to co-develop and commercialize its experimental drug designed to treat Parkinson's disease psychosis.
For details, see [ID:nBNG489486] (Reporting by Ryan Vlastelica; Editing by Theodore d'Afflisio)
WASHINGTON (Reuters) - An American Airlines Boeing 737 overshot the runway while landing at the international airport at Kingston, Jamaica on Tuesday night, the U.S. Federal Aviation Authority said.
Data security breaches are nasty business and should be avoided at all costs, writes Kevin Prince, a chief technology officer at Perimeter e-Security. Here's a look at the biggest breaches and blunders of 2009. Commentary
For most Americans, the housing market collapsed about four years ago. For three real estate heavyweights, it's just getting started. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
